Centene Corp (CNC)vsUBS Group AG (UBS)
CNC
Centene Corp
$62.33
-0.59%
HEALTHCARE · Cap: $32.19B
UBS
UBS Group AG
$47.01
-1.40%
FINANCIAL SERVICES · Cap: $165.40B
Smart Verdict
WallStSmart Research — data-driven comparison
Centene Corp generates 248% more annual revenue ($178.33B vs $51.31B). UBS leads profitability with a 17.8% profit margin vs -3.6%. UBS appears more attractively valued with a PEG of 0.90. UBS earns a higher WallStSmart Score of 79/100 (B+).
CNC
Buy57
out of 100
Grade: C
UBS
Strong Buy79
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+85.0%
Fair Value
$268.78
Current Price
$62.33
$206.45 discount
Intrinsic value data unavailable for UBS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Generating 3.4B in free cash flow
Strong operational efficiency at 31.5%
Earnings expanding 84.4% YoY
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
ROE of -30.1% — below average capital efficiency
Currently unprofitable
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : CNC
The strongest argument for CNC centers on Price/Book, Free Cash Flow. PEG of 1.25 suggests the stock is reasonably priced for its growth.
Bull Case : UBS
The strongest argument for UBS centers on Operating Margin, EPS Growth, Market Cap. Profitability is solid with margins at 17.8% and operating margin at 31.5%. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : CNC
The primary concerns for CNC are Return on Equity, Profit Margin.
Bear Case : UBS
The primary concerns for UBS are Altman Z-Score, Debt/Equity. Debt-to-equity of 4.23 is elevated, increasing financial risk.
Key Dynamics to Monitor
CNC profiles as a turnaround stock while UBS is a mature play — different risk/reward profiles.
CNC carries more volatility with a beta of 1.09 — expect wider price swings.
UBS is growing revenue faster at 13.8% — sustainability is the question.
Monitor HEALTHCARE PLANS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
UBS scores higher overall (79/100 vs 57/100), backed by strong 17.8% margins and 13.8% revenue growth. CNC offers better value entry with a 85.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Centene Corp
HEALTHCARE · HEALTHCARE PLANS · USA
Centene Corporation is a large publicly traded company and a multi-line managed care enterprise that serves as a major intermediary for both government-sponsored and privately insured health care programs. It is a healthcare insurer that focuses on managed care for uninsured, underinsured, and low-income individuals.
UBS Group AG
FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA
UBS Group AG, provides advice and financial solutions to private, institutional and corporate clients worldwide. The company is headquartered in Zurich, Switzerland.
Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?